Enrique Grande

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Enrique Grande
Sep 16, 2024, 16:31 | Societies
40 Posts Not To Miss From ESMO24 Day 3
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at the…
Sep 16, 2024, 16:18 | Societies
Key Findings from the NIAGARA Trial at ESMO 2024
The results of the NIAGARA trial were recently presented at ESMO 2024. The NIAGARA trial,…
Sep 6, 2024, 17:48 | Insight
Enrique Grande: Honored to be appointed as Adjunct Professor at the GU Medical Oncology Department at the University of Texas MD Anderson Cancer Center
Enrique Grande shared a post by MD Anderson Madrid on X, adding: "I’m deeply honored…
Aug 18, 2024, 08:27 | Blog
Enrique Grande: Amazing review from Rana McKay and Neeraj Agarwal on the new PARPi + ARSIs combos
Enrique Grande posted on X about recent paper by Rana McKay et al., titled "First-line…
Aug 12, 2024, 22:11 | Blog
Enrique Grande: Acknowledging Grupo GETNE's contribution to neuroendocrine tumors
Enrique Grande shared on X: "Maybe we should stop one day to think and acknowledge the…
Aug 10, 2024, 13:59 | Insight
New hope in treating advanced grade 3 Neuroendocrine Neoplasms - Garcia-Carbonero's Lab
Garcia-Carbonero's Lab shared a post on X: “New hope in treating advanced grade 3 Neuroendocrine…
Aug 8, 2024, 18:34 | Insight
Molecular biomarkers of progression in non-muscle-invasive bladder cancer
Enrique Grande shared a paper by Mitchell Olislagers et al. on X, adding: “Molecular biomarkers…
Jul 25, 2024, 13:04 | Blog
Enrique Grande: Failure of Trials to Enhance Outcomes in mRCC Patients Re-challenged with Immunotherapy
Enrique Grande shared a post on X: "2 phase 3 trials have failed to improve…
Jul 19, 2024, 14:41 | Blog
DOR to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation
Enrique Grande shared a post on X: ''Durable Objective Response to Lurbinectedin in Small Cell…
Jul 10, 2024, 08:31 | Blog
ASCO - Why biomarkers are needed to optimize outcomes and avoid toxicities
ASCO shared on X: "Though novel therapies have improved survival in patients with mUC, many will…
Jul 6, 2024, 13:40 | Blog
Enrique Grande: Resistance to new drugs in bladder cancer
Enrique Grande shared a post on X: “Very happy to share our contribution to ASCO…
Jul 2, 2024, 11:31 | Blog
Challenges in non-muscle invasive bladder cancer by Ashish Kamat
Enrique Grande shared on X:          . "Brilliant talk about challenges in…
Jul 2, 2024, 11:12 | Blog
Enrique Grande: Fabulous and inspiring view of the short term future of advanced bladder cancer
Enrique Grande shared a post on X:                 …
Jun 26, 2024, 15:22 | Insight
Results from the NIAGARA Phase III trial
AztraZeneca released the results of the NIAGARA phase III trial, where INFINZI (durvalumab) showed EFS…
Jun 21, 2024, 05:08 | Insight
Enrique Grande: A Molecular-Directed Strategy with TP53 Mutation in small cell bladder cancer
Enrique Grande, Head of Oncology at MD Anderson Madrid Cancer Center, recently shared a post…
Jun 20, 2024, 14:10 | Insight
Enrique Grande: Epigenomic signatures of sarcomatoid differentiation of RCC
Enrique Grande shared a post on X: "On Cell Reports - Epigenomic signatures of sarcomatoid…
May 29, 2024, 09:04 | Societies
Shilpa Gupta: Glad to present our work on physician-reported 1L treatment patterns in 5 European countries
Enrique Grande, recently shared a post by Shilpa Gupta on X, adding: "We all always…
May 23, 2024, 11:26 | Drugs
Enrique Grande: Cabozantinib with or without PD-1/L1 inhibitors for metastatic clear cell renal cell carcinoma
Enrique Grande, Head of Oncology at MD Anderson Madrid Cancer Center, recently shared a post…
May 21, 2024, 12:45 | Insight
Enrique Grande: Improving antitumor immune response via Treg reduction in bladder cancer
Enrique Grande, Head of the Medical Oncology Service and Director of Clinical Research at the MD…
Apr 24, 2024, 14:45 | Blog
Regina Barragan-Carrillo: Great discussion on RCC management with Javier Molina Cerrillo!
Regina Barragan-Carrillo, Postdoctoral fellow at City of Hope, shared a post on X: "Great discussion on…
Jan 29, 2024, 17:38 | Insight
Roberto Iacovelli: The results of CABATEN study presented at GU24
Roberto Iacovelli, Associate Professor of Medical Oncology at Catholic University, Comprehensive Cancer Center of Rome,…
Jan 20, 2024, 17:47 | Blog
Roberto Iacovelli: Wonderful presentation from my friend Enrique Grande
Roberto Iacovelli, Associate Profesor of Medical Oncology at Catholic University, Comprehensive Cancer Center of Rome,…
Dec 12, 2023, 12:40 | Societies
20 Posts Not To Miss From ESMO Asia Congress 2023
The ESMO Asia Congress 2023 took place in Singapore from 1 to 3 December. Our…
All: 23 Posts: 1 - 100
Special Coverage